Signal · Product Feed

$summit study tirzepatide Effects of on circulatory overload and end-organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the trial Has Tirzepatide Scaled the HFpEF/Obesity$

summit study tirzepatide

summit study tirzepatide Effects of on circulatory overload and end-organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the trial Has Tirzepatide Scaled the HFpEF/Obesity

Name: summit study tirzepatide Effects of on circulatory overload and end-organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the trial Has Tirzepatide Scaled the HFpEF/Obesity
Brand: www.allread.ai
SKU: 54496166378
Price: 26.40 USD
Availability: InStock
Rating: 4.4284 (9 reviews)

SKU: 54496166378

4.4

USD26.40 USD48.40

Pay in 4 interest-free payments of $6.60 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Live Spec

Has Tirzepatide Scaled the HFpEF Obesity SUMMIT? Another "Positive" Heart Failure Trial that Falls Short Reaching the SUMMIT? Benefits and potential risks associated with the use of tirzepatide in heart failure with preserved ejection fraction ScienceDirect AHA 24 Late Breaking Discussion: SUMMIT: Tirzepatide in Patients with HFpEF and Obesity Impact of Body Mass Index, Central Adiposity, and Weight Loss on the Benefits of Tirzepatide in HFpEF: The SUMMIT Trial JACC SURMOUNT 1 Trial Cardionerds Twitter Journal Club

Store: www.allread.ai · Domain: www.allread.ai

Description

This is a great time to ask any questions and learn more about the science behind peptide-assisted weight loss